Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
An Emerald Health Therapeutics Stock Forecast for 2019
Our (amazing) cannabis stock forecast for Emerald Health: 7-fold increase for 2019 and potentially 26-fold in 2020 @emeraldhealthca @EmeraldHealthHQ @EmeraldHealthHQ https://t.co/nM4MNsrtzq$EMHTF pic.twitter.com/Ilk0Rxf38B
— InvestingHaven (@InvestingHaven) September 4, 2018
Pot Stocks May Be the Latest Mania But Show No Signs of Slowing
https://www.bloomberg.com/news/articles/2018-09-04/pot-stocks-may-be-the-latest-mania-but-show-no-signs-of-slowing
Liking the consolidation in the $3.50 - $3.60 range. Need one beverage JV news and this will fly.
There was a Citron hit piece on CRON.
[OT]Widely Used Diabetes Drug Can Cause Flesh-Eating Genital Infection
https://www.bloombergquint.com/business/2018/08/29/flesh-eating-genital-infection-tied-to-rare-diabetes-drug-effect
Market is pricing the stock for something positive. No volatility as in the past two days. Let’s see if ER is AH today. I’d prefer premarket tomorrow if it shows increase in sales.
OPNT +73% /PM on EBS takeout of Adapt Pharma
Excellent analysis Chickpea. Thanks for sharing!
1.5M shares traded. Accumulation going on. Healthy pullback indeed.
Snack Makers Looking To Develop Edible Marijuana Products
https://grizzle.com/snack-makers-marijuana-edibles/
Pot stocks rampage amid expectations of more big deals with traditional companies
https://www.marketwatch.com/story/pot-stocks-rampage-amid-expectations-of-more-big-deals-with-traditional-companies-2018-08-24
“Report says Smirnoff maker is looking for pot partner, after $4 billion investment in Canopy by booze giant Constellation”
It's On Like Donkey Kong: Aurora Cannabis and Canopy Growth Battle Over Softgel Capsules
https://www.fool.com/investing/2018/08/27/its-on-like-donkey-kong-aurora-cannabis-and-canopy.aspx
Missing the big news from EMHTF from this morning.
I like the growth potential with EMHTF. Only a matter of time.
PTIE -50% on $11M direct offering
$PTIE - $11M Direct Offering Tanked the stock today - down 48% - pic.twitter.com/ATt4ZS0mKj
— Ospreyeye (@MyChartCoachcom) August 16, 2018
Agreed! (eom)
Most valuable unpartnered assets reveal a changing of the guard
http://www.evaluate.com/vantage/articles/data-insights/other-data/most-valuable-unpartnered-assets-reveal-changing-guard
3-D Color X-Rays Could Help Spot Deadly Disease Without Surgery
https://www.nytimes.com/2018/07/17/health/3d-color-xrays-cern.html
—A new medical scanner, derived from technology used by particle physics researchers at CERN, “is like the upgrade from black-and-white film to color,” one of its developers said.
Why aluminum tariffs are hurting Alcoa more than helping
https://www.marketwatch.com/story/why-trump-administrations-aluminum-tariffs-are-hurting-alcoa-more-than-helping-2018-07-19
Graphene could make your computer 1,000 times faster, while using only 1% of the power
Graphene could make your computer 1,000 times faster, while using only 1% of the power. https://t.co/471QvrtgGk pic.twitter.com/jiEYfT6lld
— Vala Afshar (@ValaAfshar) July 12, 2018
T cell engineering breakthrough sidesteps need for viruses in gene-editing
https://www.sciencedaily.com/releases/2018/07/180711131204.htm
Very sad and unfortunate news. May lasers Rest In Peace. I didn’t know lasers personally but it was evident from his/her posts that he/she had a positive outlook on life and cancer treatment.
I agree with you Jeff that there are bigger things in life than trading stocks and we need to live each moment to the fullest.
The US is pumping out more oil than 12 of 14 OPEC members.
https://read.bi/2zatxSi
Governments Explore Using Blockchains to Improve Service https://nyti.ms/2N3P16p
Walgreens, CVS and Rite-Aid lose $12 billion in value after Amazon buys online pharmacy PillPack
https://www.cnbc.com/2018/06/28/walgreens-cvs-shares-tank-after-amazon-buys-online-pharmacy-pillpack.html
The ‘Right to Try’ Could Cost Dying Patients a Fortune
https://www.bloomberg.com/news/articles/2018-06-20/the-price-to-try-a-drug-could-be-300-000-for-dying-patients
$MDGL working with centerview on potential sale amid takeover interest...obv would be good for $VKTX given valuation disparity, others $ICPT
— zach (@zbiotech) June 13, 2018
Gold Market Dreams of Blockchain Supply Chain by Next Year
https://www.bloomberg.com/news/articles/2018-06-06/gold-market-could-put-supply-on-blockchain-as-soon-as-next-year
Merck cements its position as dominant developer of immunotherapy
—Patients taking group’s lung cancer drug lived longer than those on chemotherapy
https://www.ft.com/content/050fab26-66b0-11e8-8cf3-0c230fa67aec
MADRIGAL PRICE TARGET RAISED TO STREET-HIGH $400 AT ROTH
*MADRIGAL PRICE TARGET RAISED TO STREET-HIGH $400 AT ROTH$MDGL
— Mz Trading (@trading_mz) June 1, 2018
Agreed.
$VKTX insider open mkt purchases this wk by COB and 3 other directors were their first open mkt/direct holdings
— zach (@zbiotech) June 1, 2018
-macartney (COB) +48K @ $5.22
-rowland +30K @ $5.16
-webster +8K @ $5.21
-singleton +9.5K @ $9.82
CFO:
-morneau (22K) @ $9.25, now currently holds 94K direct
I completely agree with you. My statement was based on dialogues I had with a friend who is more knowledgeable than me in the field and was not based on hard facts. I should have made that clear that it was just an opinion or better, refrained from saying that. So please take it with a grain of salt.
Lastly if there is a rising tide of big pharma positive LAG-3 data, it should also lift IMMP at/post ASCO.
Fun fact on IMMP (ADRs)—You can get a good sense of how it will trade on Nasdaq by following the stock in the Australian stock exchange which is 12 hours ahead of us.
https://www.google.com/search?q=asx%20imm
LAG-3 could be as big, if not bigger than PD-1. IMMP’s data thus far and its relatively small valuation leaves much room for growth, IMO.
https://medium.com/@Innoplexus/whats-next-in-immune-checkpoints-is-lag-3-emerging-as-a-potential-combination-partner-with-pd-1-aed11b56fb4b
LAG-3: Immuno-oncology researchers seek to build smart drug combos
https://www.novartis.com/stories/discovery/immuno-oncology-researchers-seek-build-smart-drug-combos
1st NVS(/IMMP) ASCO abstract:
https://twitter.com/finicky_cynic/status/1001599520462041088?s=21
2nd NVS(/IMMP) ASCO abstract:
https://twitter.com/finicky_cynic/status/1001599855339474946?s=21
Quite the spread here. Since abstracts $IMMP up the most in percentage terms (37%), while others have drifted in line with rest of the sector. GITR and agonists as a class the biggest loser out of abstracts
— Vk (@biotechinvstr) May 31, 2018
VKTX +76% on MDGL pop (EOM)
MDGL HoD $256! (eom)
Disclaimer: Edison report is paid for by the company.